Get Our FREE Newsletter

Sign Up

Merck (MRK) Seeks Emergency Nod for Oral Antiviral COVID-19 Pill

Spread the love

Merck & Co., Inc. MRK, along with partner Ridgeback Biotherapeutics, announced that they have filed an application seeking Emergency Use Authorization (“EUA”) for investigational oral antiviral medicine, molnupiravir, for the treatment of mild-to-moderate COVID-19 in

This post was originally published on this site